$3.71
-0.24-6.08%
Pre-Market: Jul 9, 4:00 PM EDT
15 minutes delayed
Aprea Therapeutics
APRENASDAQ
Aprea Therapeutics (NASDAQ:APRE) Stock, Insider Trading Activity
Aprea Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Aprea Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Aprea Therapeutics Inc
Institutional Shares Held
211.576K
Institutional Percentage Held
3.90%
| Mar 14, 2024 | John Hamill | SRVP/CFO/PRIN FIN & ACCT OFCR | 1.01K | $7.29 | $7.36K | BUY | 6.97% | 15.50K | Mar 13 | View |
| Mar 14, 2024 | Bernd Seizinger | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 25.57% | 33.69K | Mar 13 | View |
| Mar 14, 2024 | JOHN HENNEMAN III | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 536.36% | 8.14K | Mar 13 | View |
| Mar 14, 2024 | Oren Gilad | PRESIDENT, CEO | 2.00K | $7.29 | $14.58K | BUY | 0.62% | 324.77K | Mar 13 | View |
| Jun 08, 2023 | Bernd Seizinger | DIRECTOR | 10.10K | $3.66 | $36.96K | BUY | 62.22% | 26.32K | Jun 06 - Jun 07 | View |
| May 19, 2022 | Bernd Seizinger | DIRECTOR | 50.00K | $0.71 | $35.50K | BUY | 18.62% | 318.58K | May 18 | View |
| May 19, 2022 | CHRISTIAN SCHADE | CHAIRMAN & CEO | 37.50K | $0.64 | $24.12K | BUY | 14.42% | 297.62K | May 18 | View |
| Mar 01, 2022 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -36.00K | $1.73 | -$62.28K | SELL | -43.29% | 47.16K | Feb 28 | View |
| Dec 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.44 | -$83.60K | SELL-OPTIONS | 0.00% | 17.17K | Dec 01 | View |
| Nov 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.96 | -$112.20K | SELL-OPTIONS | 0.00% | 17.17K | Nov 01 | View |
| Oct 05, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $2.90 | -$198.50K | SELL-OPTIONS | 0.00% | 19.00K | Oct 01 | View |
| Oct 05, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.90 | -$109.17K | SELL-OPTIONS | 0.00% | 17.17K | Oct 01 | View |
| Sep 22, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | -5.46K | $2.95 | -$138.57K | SELL | -24.13% | 17.17K | Sep 20 | View |
| Sep 22, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $2.94 | -$101.25K | SELL-OPTIONS | 0.00% | 19.00K | Sep 20 | View |
| Sep 20, 2021 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -15.97K | $4.68 | -$74.73K | SELL | -16.11% | 83.16K | Sep 16 | View |
| Feb 16, 2021 | Redmile Group LLCJeremy Green | 10% OWNER | -500.00K | $5.58 | -$2.79M | SELL | -22.04% | 1.77M | Dec 28 | View |
| Oct 07, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCAM Opportunities I LPAM Opportunities I GP LLCJOHN DIEKMANAndrew SchwabKUSH PARMARSCOTT ROCKLAGE | — | -175.00K | $25.30 | -$4.43M | SELL | -44.93% | 214.46K | Oct 05 | View |
| Jul 07, 2020 | AB Investments KDevAB Development KarolinskaKB Fund CoInvestment KCIF | — | -241.70K | $34.55 | -$8.35M | SELL | -10.82% | 1.99M | Jul 07 | View |
| Jun 18, 2020 | Scott M Rocklage | — | -120.16K | $33.30 | -$4.00M | SELL | -61.27% | 75.97K | Jun 16 | View |
| Jun 18, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -140.00K | $33.30 | -$4.66M | SELL | -30.87% | 313.50K | Jun 16 | View |
| Jun 15, 2020 | Scott M Rocklage | — | -245.00K | $28.75 | -$7.04M | SELL | -75.21% | 80.77K | Jun 11 | View |
| Jun 15, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -245.00K | $28.75 | -$7.04M | SELL | -37.17% | 414.11K | Jun 11 | View |
| May 21, 2020 | Scott M Rocklage | — | -255.00K | $35.15 | -$8.96M | SELL | -73.79% | 90.57K | May 19 | View |
| May 21, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -255.00K | $35.15 | -$8.96M | SELL | -37.56% | 423.90K | May 19 | View |
| Apr 15, 2020 | AB Investments KDevAB Development KarolinskaKB Fund CoInvestment KCIF | — | -210.55K | $31.25 | -$6.58M | SELL | -8.61% | 2.23M | Apr 13 | View |
| Oct 09, 2019 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCAM Opportunities I LPAM Opportunities I GP LLCJOHN DIEKMANAndrew SchwabKUSH PARMAR | 10% OWNER | 2.84M | $15.00 | $5.00M | BUY | ∞ | 333.33K | Oct 07 | View |
| Oct 08, 2019 | Redmile Group LLCJeremy Green | 10% OWNER | 2.27M | $15.00 | $6.00M | BUY | ∞ | 2.27M | Oct 07 | View |
| Oct 07, 2019 | HealthCap VII LPSA GP HealthCap VII | 10% OWNER | 2.36M | $15.00 | $4.00M | BUY | 22308.41% | 2.37M | Oct 07 | View |
| Oct 07, 2019 | Versant Vantage I LPVersant Vantage I GP LPVersant Vantage I GPGP LLC | — | 2.84M | $15.00 | $5.00M | BUY | ∞ | 333.33K | Oct 07 | View |
| Oct 07, 2019 | rl Sa Luxco Versant VVersant Ventures V LLCVersant Ventures V GPGP Canada IncVersant Ventures V Canada LPVersant Venture Capital V Canada LPVersant Affiliates Fund V LPVersant Ophthalmic Affiliates I LPVersant Venture Capital V LP | — | 2.84M | $15.00 | $5.00M | BUY | ∞ | 333.33K | Oct 07 | View |
| Oct 07, 2019 | Johan Christenson | — | 2.36M | $15.00 | $4.00M | BUY | 22308.41% | 2.37M | Oct 07 | View |
| Oct 07, 2019 | Guido Magni | — | 6.50K | $15.00 | $97.50K | BUY | ∞ | 6.50K | Oct 07 | View |
| Oct 07, 2019 | JOHN HENNEMAN III | — | 5.00K | $15.00 | $75.00K | BUY | ∞ | 5.00K | Oct 07 | View |
| Oct 07, 2019 | Alan Gregory Korbel | VP BUSINESS DEV'T | 500.00 | $15.00 | $7.50K | BUY | ∞ | 500.00 | Oct 07 | View |
| Oct 07, 2019 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | 400.00 | $15.00 | $6.00K | BUY | ∞ | 200.00 | Oct 07 | View |
| Oct 07, 2019 | Scott M Coiante | SVP, CHIEF FINANCIAL OFFICER | 2.50K | $15.00 | $37.50K | BUY | ∞ | 2.50K | Oct 07 | View |
| Oct 07, 2019 | CHRISTIAN SCHADE | PRESIDENT & CEO | 11.00K | $15.00 | $165.00K | BUY | ∞ | 5.16K | Oct 07 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.